Accepted Articles                   Back to the articles list | Back to browse issues page

XML Print

This article has no abstract.
Type of Study: Original | Subject: Cellular and molecular Neuroscience
Received: 2018/06/26 | Accepted: 2018/06/26 | Published: 2018/06/26

1. Park H-Y, Shin C, Lim K. Intermittent hypoxic training for 6 weeks in 3000 m hypobaric hypoxia conditions enhances exercise economy and aerobic exercise performance in moderately trained swimmers. Biology of sport. 2018;35(1):49-56. [DOI:10.5114/biolsport.2018.70751] [PMID] [PMCID]
2. Slivka DR, Heesch MW, Dumke CL, Cuddy JS, Hailes WS, Ruby BC. Human skeletal muscle mRNAResponse to a single hypoxic exercise bout. Wilderness Environ Med. 2014;25(4):462-5. [DOI:10.1016/j.wem.2014.06.011] [PMID]
3. Morici G, Bonanno A, Licciardi A, Valli G, Passino C, Bonardi D, et al. Plasma leptin and vascular endothelial growth factor (VEGF) in normal subjects at high altitude (5050 m). Archives of physiology and biochemistry. 2013;119(5):219-24. [DOI:10.3109/13813455.2013.814679] [PMID]
4. Kasai N, Kojima C, Sumi D, Takahashi H, Goto K, Suzuki Y. Impact of 5 Days of Sprint Training in Hypoxia on Performance and Muscle Energy Substances. International journal of sports medicine. 2017;38(13):983-91. [DOI:10.1055/s-0043-117413] [PMID]
5. Hoppeler H, Vogt M. Muscle tissue adaptations to hypoxia. J Exp Biol. 2001;204(Pt 18):3133-9.
6. McLean BD, Gore CJ, Kemp J. Application of 'live low-train high' for enhancing normoxic exercise performance in team sport athletes. Sports medicine (Auckland, NZ). 2014;44(9):1275-87. [DOI:10.1007/s40279-014-0204-8] [PMID]
7. Levine BD, Stray-Gundersen J. Dose-response of altitude training: how much altitude is enough? Adv Exp Med Biol. 2006;588:233-47. [DOI:10.1007/978-0-387-34817-9_20] [PMID]
8. Mounier R, Pialoux V, Roels B, Thomas C, Millet G, Mercier J, et al. Effect of intermittent hypoxic training on HIF gene expression in human skeletal muscle and leukocytes. European journal of applied physiology. 2009;105(4):515-24. [DOI:10.1007/s00421-008-0928-y] [PMID]
9. Friedmann-Bette B. Classical altitude training. Scandinavian journal of medicine & science in sports. 2008;18 Suppl 1:11-20. [DOI:10.1111/j.1600-0838.2008.00828.x] [PMID]
10. Hoppeler H, Klossner S, Vogt M. Training in hypoxia and its effects on skeletal muscle tissue. Scandinavian journal of medicine & science in sports. 2008;18 Suppl 1:38-49. [DOI:10.1111/j.1600-0838.2008.00831.x] [PMID]
11. Lundby C, Calbet JA, Robach P. The response of human skeletal muscle tissue to hypoxia. Cell Mol Life Sci. 2009;66(22):3615-23. [DOI:10.1007/s00018-009-0146-8] [PMID]
12. Abe T, Kitaoka Y, Kikuchi DM, Takeda K, Numata O, Takemasa T. High-intensity interval training-induced metabolic adaptation coupled with an increase in Hif-1alpha and glycolytic protein expression. Journal of applied physiology (Bethesda, Md : 1985). 2015;119(11):1297-302. [DOI:10.1152/japplphysiol.00499.2015] [PMID]
13. Gore CJ, Hahn AG, Aughey RJ, Martin DT, Ashenden MJ, Clark SA, et al. Live high:train low increases muscle buffer capacity and submaximal cycling efficiency. Acta Physiol Scand. 2001;173(3):275-86. [DOI:10.1046/j.1365-201X.2001.00906.x] [PMID]
14. Semenza GL. Targeting HIF-1 for cancer therapy. Nature reviews Cancer. 2003;3(10):721-32. [DOI:10.1038/nrc1187] [PMID]
15. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451(7181):1008-12. [DOI:10.1038/nature06613] [PMID]
16. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han DH, Chen MM, et al. A role for the transcriptional coactivator PGC-1alpha in muscle refueling. The Journal of biological chemistry. 2007;282(50):36642-51. [DOI:10.1074/jbc.M707006200] [PMID]
17. Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor. The Journal of biological chemistry. 2002;277(3):1645-8. [DOI:10.1074/jbc.C100631200] [PMID]
18. Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. Faseb j. 2002;16(14):1879-86. [DOI:10.1096/fj.02-0367com] [PMID]
19. Pilegaard H, Saltin B, Neufer PD. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. The Journal of physiology. 2003;546(Pt 3):851-8. [DOI:10.1113/jphysiol.2002.034850] [PMID] [PMCID]
20. Ameln H, Gustafsson T, Sundberg CJ, Okamoto K, Jansson E, Poellinger L, et al. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. Faseb j. 2005;19(8):1009-11. [DOI:10.1096/fj.04-2304fje] [PMID]
21. O'Hagan KA, Cocchiglia S, Zhdanov AV, Tambuwala MM, Cummins EP, Monfared M, et al. PGC-1α is coupled to HIF-1α-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. 2009;106(7):2188-93. [DOI:10.1073/pnas.0808801106] [PMID] [PMCID]
22. Zoll J, Ponsot E, Dufour S, Doutreleau S, Ventura-Clapier R, Vogt M, et al. Exercise training in normobaric hypoxia in endurance runners. III. Muscular adjustments of selected gene transcripts. Journal of applied physiology (Bethesda, Md : 1985). 2006;100(4):1258-66. [DOI:10.1152/japplphysiol.00359.2005] [PMID]
23. Park H-Y, Lim K. Effects of Hypoxic Training versus Normoxic Training on Exercise Performance in Competitive Swimmers. Journal of sports science & medicine. 2017;16(4):480-8.
24. Bonetti DL, Hopkins WG. Sea-level exercise performance following adaptation to hypoxia: a meta-analysis. Sports medicine (Auckland, NZ). 2009;39(2):107-27. [DOI:10.2165/00007256-200939020-00002] [PMID]
26. Roohollah MH, Shadmehr M. The Effect of an Inspiratory Muscle Training Period at High Altitude on Arterial Oxygen Saturation and Performance of Iran's National Team Endurance Runners. Journal of Pulmonary & Respiratory Medicine. 2016(6):3. [DOI:10.4172/2161-105X.1000356]
27. Soori R, Safei A, Pournemati P, Ghram A. Green tea consumption reduces apelin and orexin-A in overweight and obese women with different training modalities. J Sport Sciences for Health. 2018;14(2):421-31. [DOI:10.1007/s11332-018-0462-1]
28. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. Journal of applied physiology (Bethesda, Md : 1985). 2000;88(4):1474-80. [DOI:10.1152/jappl.2000.88.4.1474] [PMID]
29. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med. 2004;36(1):1-12. [DOI:10.1038/emm.2004.1] [PMID]
30. Vogt M, Puntschart A, Geiser J, Zuleger C, Billeter R, Hoppeler H. Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions. Journal of applied physiology (Bethesda, Md : 1985). 2001;91(1):173-82. [DOI:10.1152/jappl.2001.91.1.173] [PMID]
31. Faiss R, Leger B, Vesin JM, Fournier PE, Eggel Y, Deriaz O, et al. Significant molecular and systemic adaptations after repeated sprint training in hypoxia. PloS one. 2013;8(2):e56522. [DOI:10.1371/journal.pone.0056522] [PMID] [PMCID]
32. Lundby C, Gassmann M, Pilegaard H. Regular endurance training reduces the exercise induced HIF-1alpha and HIF-2alpha mRNA expression in human skeletal muscle in normoxic conditions. European journal of applied physiology. 2006;96(4):363-9. [DOI:10.1007/s00421-005-0085-5] [PMID]
33. Pialoux V, Brugniaux JV, Fellmann N, Richalet JP, Robach P, Schmitt L, et al. Oxidative stress and HIF-1 alpha modulate hypoxic ventilatory responses after hypoxic training on athletes. Respir Physiol Neurobiol. 2009;167(2):217-20. [DOI:10.1016/j.resp.2009.04.012] [PMID]
34. Gustafsson T, Knutsson A, Puntschart A, Kaijser L, Nordqvist AC, Sundberg CJ, et al. Increased expression of vascular endothelial growth factor in human skeletal muscle in response to short-term one-legged exercise training. Pflugers Arch. 2002;444(6):752-9. [DOI:10.1007/s00424-002-0845-6] [PMID]
35. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE. 2007;2007(407):cm8. [DOI:10.1126/stke.4072007cm8] [PMID]
36. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (New York, NY). 2001;292(5516):464-8. [DOI:10.1126/science.1059817] [PMID]
37. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (New York, NY). 2001;292(5516):468-72. [DOI:10.1126/science.1059796] [PMID]
38. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399(6733):271-5. [DOI:10.1038/20459] [PMID]
39. Tacchini L, De Ponti C, Matteucci E, Follis R, Desiderio MA. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines. Carcinogenesis. 2004;25(11):2089-100. [DOI:10.1093/carcin/bgh227] [PMID]
40. Zhou J, Schmid T, Brune B. Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway. Mol Biol Cell. 2003;14(6):2216-25. [DOI:10.1091/mbc.e02-09-0598] [PMID] [PMCID]
41. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. The Journal of biological chemistry. 2000;275(35):26765-71. [DOI:10.1074/jbc.M003325200]
42. Scott GR, Elogio TS, Lui MA, Storz JF, Cheviron ZA. Adaptive Modifications of Muscle Phenotype in High-Altitude Deer Mice Are Associated with Evolved Changes in Gene Regulation. Mol Biol Evol. 2015;32(8):1962-76. [DOI:10.1093/molbev/msv076] [PMID] [PMCID]
43. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, Zhang CY, et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell. 2001;8(5):971-82. [DOI:10.1016/S1097-2765(01)00390-2]
44. Jager S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A. 2007;104(29):12017-22. [DOI:10.1073/pnas.0705070104] [PMID] [PMCID]
45. Levine BD, Stray-Gundersen J. "Living high-training low": effect of moderate-altitude acclimatization with low-altitude training on performance. Journal of applied physiology (Bethesda, Md : 1985). 1997;83(1):102-12. [DOI:10.1152/jappl.1997.83.1.102] [PMID]
46. Robertson EY, Saunders PU, Pyne DB, Gore CJ, Anson JM. Effectiveness of intermittent training in hypoxia combined with live high/train low. European journal of applied physiology. 2010;110(2):379-87. [DOI:10.1007/s00421-010-1516-5] [PMID]
47. Neya M, Enoki T, Kumai Y, Sugoh T, Kawahara T. The effects of nightly normobaric hypoxia and high intensity training under intermittent normobaric hypoxia on running economy and hemoglobin mass. Journal of applied physiology (Bethesda, Md : 1985). 2007;103(3):828-34. [DOI:10.1152/japplphysiol.00265.2007] [PMID]
48. Julian CG, Gore CJ, Wilber RL, Daniels JT, Fredericson M, Stray-Gundersen J, et al. Intermittent normobaric hypoxia does not alter performance or erythropoietic markers in highly trained distance runners. Journal of applied physiology (Bethesda, Md : 1985). 2004;96(5):1800-7. [DOI:10.1152/japplphysiol.00969.2003] [PMID]
49. Rodriguez FA, Truijens MJ, Townsend NE, Stray-Gundersen J, Gore CJ, Levine BD. Performance of runners and swimmers after four weeks of intermittent hypobaric hypoxic exposure plus sea level training. Journal of applied physiology (Bethesda, Md : 1985). 2007;103(5):1523-35. [DOI:10.1152/japplphysiol.01320.2006] [PMID]
50. Millet GP, Roels B, Schmitt L, Woorons X, Richalet JP. Combining hypoxic methods for peak performance. Sports medicine (Auckland, NZ). 2010;40(1):1-25. [DOI:10.2165/11317920-000000000-00000] [PMID]

Add your comments about this article : Your username or Email:

© 2020 All Rights Reserved | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb